Journal Mobile Options
Table of Contents
Vol. 87, No. 3, 2008
Issue release date: April 2008
Neuroendocrinology 2008;87:142–150

Interplay between Dose and Frequency of GnRH Administration in Determining Pituitary Gonadotropin Responsiveness

Hughes V.A. · Boepple P.A. · Crowley, Jr. W.F. · Seminara S.B.
Harvard Reproductive Endocrine Sciences Center and Reproductive Endocrine Unit, Department of Medicine and Department of Pediatrics, Massachusetts General Hospital, Boston, Mass., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background/Aims: The dose, frequency and contour of GnRH stimulation of the pituitary gonadotrope have been shown to be independent variables influencing pituitary LH secretion. The dynamic interaction between these variables during physiological and pathophysiological states has yet to be examined. Methods: Twelve men with GnRH deficiency and idiopathic hypogonadotropic hypogonadism undergoing GnRH therapy participated in a series of studies in which 2 log orders of GnRH doses (2.5–250 ng/kg) were administered at frequencies varying from 0.5 to 8 hourly. Pituitary responses were characterized by pulse amplitudes and nadirs. The relative sensitivity of the gonadotrope to GnRH was defined as that dose of GnRH capable of eliciting an LH pulse amplitude equal to the mean LH amplitude in normal men. Results: As GnRH stimulation of the gonadotrope slowed from 0.5 to 8 hourly, pulse amplitudes of LH increased whereas mean nadirs decreased (p < 0.05). Unique, curvilinear dose-response curves were found for each frequency that demonstrated an increasing slope (p < 0.03) as the frequency of GnRH stimulation slowed. Thus, the relative sensitivity of the gonadotrope increased as the frequency of GnRH stimulation decreased over the range of physiological frequencies tested. Conclusions: We conclude that a delicate interplay exists between the dose and frequency of GnRH stimulation of the gonadotrope that determines pituitary LH gonadotropin responsiveness in the human. Slower frequencies favor increased LH release largely due to decreasing LH nadirs and improved sensitivity of the gonadotropes to GnRH stimulation.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Kastin AJ, Schally AV, Gual C, Midgley AR Jr, Miller MC, Cabeza A: Dose-response relationship of luteinizing hormone to luteinizing hormone-releasing hormone in man. J Clin Invest 1971;50:1551–1553.
  2. Rebar R, Yen SSC, Vandenberg G, Naftolin F, Ehara Y, Engblom S, Ryan KJ, Rivier J, Amoss M, Guillemin R: Gonadotropin responses to synthetic LRF: dose-response relationship in men. J Clin Endocrinol Metab 1973;36:10–16.
  3. Kelch RP, Clemens LE, Markovs M, Westhoff MH, Hawkins DW: Metabolism and effects of synthetic gonadotropin-releasing hormone (GnRH) in children and adults. J Clin Endocrinol Metab 1975;40:53–61.
  4. Franchimont P, Becker H, Ernould C, Thys C, Demoulin A, Bourguignon JP, Legros JJ, Valcke JC: The effect of hypothalamic luteinizing hormone releasing hormone (LH-RH) on plasma gonadotrophin levels in normal subjects. Clin Endocrinol 1974;3:27–39.
  5. Synder PJ, Reitano JF, Utiger RD: Serum LH and FSH responses to synthetic gonadotropin-releasing hormone in normal men. J Clin Endocrinol 1975;41:938–945.

    External Resources

  6. Wollesen F, Swerdloff RS, Odell WD: LH and FSH responses to luteinizing-releasing hormone in normal, adult, human males. Metabolism 1976;25:845–863.
  7. Huseman CA, Kelch RP: Gonadotropin responses and metabolism of synthetic gonadotropin-releasing hormone (GnRH) during constant infusion of GnRH in men and boys with delayed adolescence. J Clin Endocrinol 1978;47:1325–1331.
  8. Carmel PW, Araki S, Ferin M: Pituitary stalk portal blood collection in rhesus monkeys: evidence for pulsatile release of gonadotropin-releasing hormone. Endocrinology 1976;99:243–248.
  9. Spratt DI, Chin WW, Ridgway EC, Crowley WF Jr: Administration of low dose pulsatile gonadotropin-releasing hormone (GnRH) to GnRH-deficient men regulates free-alpha subunit secretion. J Clin Endocrinol Metab 1986;62:102–107.
  10. Spratt DI, O’Dea LStL, Schoenfeld D, Butler J, Rao PN, Crowley WF Jr: Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am J Physiol 1988;254:E658–E666.
  11. Spratt DI, Finkelstein JS, Badger TM, Butler JP, Crowley WF Jr: Bio- and immunoactive luteinizing hormone responses to low doses of gonadotropin-releasing hormone (GnRH): dose-response curves in GnRH-deficient men. J Clin Endocrinol Metab 1986;63:143–150.
  12. Spratt DI, Finkelstein JS, Butler JP, Badger TM, Crowley WF Jr: Effects of increasing the frequency of low doses of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion in GnRH-deficient men. J Clin Endocrinol Metab 1987;64:1179–1185.
  13. Finkelstein JS, Badger TM, O’Dea LS, Spratt DI, Crowley WF Jr: Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells. J Clin Invest 1988;81:1725–1733.
  14. Hoffman AR, Crowley WF Jr: Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. N Engl J Med 1982;307:1237–1241.
  15. Yialamas M, Dwyer A, Hanley E, Lee H, Pitteloud N, Hayes FJ: Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2007 [Epub ahead of print].
  16. Crowley WF Jr, Beitins IZ, Vale W, Kliman B, Rivier J, Rivier C, McArthur JW: The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men. N Engl J Med 1980;302:1052–1057.
  17. Filicori M, Santoro N, Merriam GR, Crowley WF Jr: Characterization of the physiologic pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab 1986;62:1136–1144.
  18. Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley WF Jr: Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab 1988;66:165–172.
  19. Burger CW, Korsen T, van Kessel H, Van Dop PA, Caron FJM, Shoemaker J: Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non PCOD secondary amenorrhea. J Clin Endocrinol.Metab 2007;61:1126–1132.

    External Resources

  20. Finkelstein JS, Whitcomb RW, O’Dea LS, Longcope C, Schoenfeld DA, Crowley WF Jr: Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab 1991;73:609–620.
  21. Hayes FJ, Seminara SB, Decruz S, Boepple PA, Crowley WF Jr: Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab 2000;85:3027–3035.
  22. Veldhuis JD, Dufau ML: Estradiol modulates the pulsatile secretion of biologically active luteinizing hormone in man. J Clin Invest 1987;80:631–638.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50